The Company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent ...
Sharps Technology, Inc., a traditionally oriented, Nasdaq-listed company (STSS) that typically specializes in medical devices and pharmaceutical packaging, became the latest to jump on the Solana ...
The Company will launch its digital asset treasury strategy under which the principal holding will be SOL, the native digital asset of the Solana blockchain. Solana is the fastest and most used public ...
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (STSS) (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company ...
--Nephron Pharmaceuticals Corporation and Sharps Technology, Inc., an innovative medical device and drug delivery company offering patented, best-in-class syringe products, announced today a new ...
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Sharps Technology, Inc. (the "Company" or "Sharps Technology") (Nasdaq: "STSS" and "STSSW") today announced its first acquisition of Solana ("SOL") tokens as ...
Sharps Technology Inc. 競合他社・同業他社分析 - Industrial Applications and Services セクター
Our AI model demonstrates 67% historical accuracy for STSS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
VAR_0__株価予測に影響を与える要因は何か?
当社の分析では、Sharps Technology Inc.の財務指標、Industrial Applications and Servicesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。